Search results
Novo’s Blockbuster Ozempic Among FTC’s Latest Patent Targets
Bloomberg Law· 3 days agoOzempic and Victoza are among 20 branded drugs the Federal Trade Commission is targeting as it challenges more than 300 “junk patent listings” in the FDA’s registry of approved drugs in an effort ...
Regeneron (REGN) Q1 Earnings, Sales Miss on Lower Eylea Sales
Zacks· 1 day agoRegeneron (REGN) reports Q1 results, wherein both the top and bottom lines miss estimates due to lower Eylea sales. Shares down.
Amarin's (AMRN) Q1 Earnings and Revenues Surpass Estimates
Zacks· 2 days agoAmarin (AMRN) posts better-than-expected first-quarter 2024 results. Vascepa's sales in the United States continue to be hurt by generic competition.
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
NBC Washington· 3 days agoFederal regulators are challenging patents on 20 brand name drugs, including the blockbuster...
EU and UK Consider First Stand-Alone Disparagement Cases | JD Supra
JD Supra· 4 days agoThe development of case law on disparagement has, to date, been driven mainly by the French competition authority, or has been addressed under consumer protection or other ...
Organon & Co (OGN) Q1 2024 Earnings: Exceeds Revenue Expectation
Guru Focus· 1 day agoRevenue: Reported at $1,622 million for Q1 2024, marking a 5% increase year-over-year and surpassing the estimated $1,563.20 million.Net Income: Achieved $201
US challenges ‘bogus’ patents on Ozempic and other drugs in effort to spur competition
KOLR - KSFX Ozarks· 3 days agoWASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration target…
Novartis Is Tracking Well Above the Industry
GuruFocus.com via Yahoo Finance· 2 days agoSource: GuruFocus Conclusion In our assessment, increased competition in the global cancer therapeutics market from Merck (NYSE:MRK) and AstraZeneca...
Ozempic and 19 other drugs have 'junk' patents, the FTC says in a new challenge
Quartz· 3 days agoThe U.S. Federal Trade Commission (FTC) announced on Tuesday that it is disputing over 300 patent...
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
Dayton Daily News· 3 days agoWASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration ...